Metalloproteinases and Vulnerable Atherosclerotic Plaques
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Plaque rupture is the main cause of myocardial infarctions and strokes. Ruptured plaques have thin, highly inflamed, and collagen-poor fibrous caps that contain elevated levels of proteases, including metalloproteinases (MMPs), which might weaken plaque caps and promote rupture. On the other hand, MMPs facilitate migration and proliferation vascular smooth muscle cells, which should promote fibrous cap stability. Given the dual effects of MMPs, therapies should selectively target harmful MMPs or the processes that cause MMP activity to rise to destructive levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure and function of matrix metalloproteinases and TIMPs
NAGASE, H., VISSE, R., & MURPHY, G. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.12.002 · Cited by 3,409
Crisby, M., Nordin-Fredriksson, G., Shah, P. K., Yano, J., Zhu, J., & Nilsson, J. (2001) · Circulation · doi:10.1161/01.cir.103.7.926 · Cited by 1,001
Newby, A. C. (2005) · Physiological Reviews · doi:10.1152/physrev.00048.2003 · Cited by 817
Self-citationRole of the Matrix Metalloproteinase and Plasminogen Activator–Plasmin Systems in Angiogenesis
Pepper, M. S. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0701.093685 · Cited by 777
Sukhova, G. K., Schönbeck, U., Rabkin, E., Schoen, F. J., Poole, A. R., Billinghurst, R. C., & Libby, P. (1999) · Circulation · doi:10.1161/01.cir.99.19.2503 · Cited by 657
Aikawa, M., Rabkin, E., Sugiyama, S., Voglic, S. J., Fukumoto, Y., Furukawa, Y., Shiomi, M., Schoen, F. J., & Libby, P. (2001) · Circulation · doi:10.1161/01.cir.103.2.276 · Cited by 588
Marx, N., Schönbeck, U., Lazar, M. A., Libby, P., & Plutzky, J. (1998) · Circulation Research · doi:10.1161/01.res.83.11.1097 · Cited by 587
Galis, Z. S., Sukhova, G. K., Kranzhöfer, R., Clark, S., & Libby, P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.2.402 · Cited by 556
Aikawa, M., Rabkin, E., Okada, Y., Voglic, S. J., Clinton, S. K., Brinckerhoff, C. E., Sukhova, G. K., & Libby, P. (1998) · Circulation · doi:10.1161/01.cir.97.24.2433 · Cited by 555
Macrophages in Human Atheroma Contain PPARγ
Marx, N., Sukhova, G., Murphy, C., Libby, P., & Plutzky, J. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65540-x · Cited by 529
Cited by
Inflammation and plaque vulnerability
Hansson, G. K., Libby, P., & Tabas, I. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12406 · Cited by 805
Cardiovascular risk of smoking and benefits of smoking cessation
Gallucci, G., Tartarone, A., Lerose, R., Lalinga, A. V., & Capobianco, A. M. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd.2020.02.47 · Cited by 491
Coronary Microembolization: From Bedside to Bench and Back to Bedside
Heusch, G., Kleinbongard, P., Böse, D., Levkau, B., Haude, M., Schulz, R., & Erbel, R. (2009) · Circulation · doi:10.1161/circulationaha.109.888784 · Cited by 419
Monocytes in Coronary Artery Disease and Atherosclerosis
Ghattas, A., Griffiths, H. R., Devitt, A., Lip, G. Y. H., & Shantsila, E. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.07.043 · Cited by 375
The biology behind the atherothrombotic effects of cigarette smoke
Csordas, A., & Bernhard, D. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.8 · Cited by 343
Martínez, G. J., Celermajer, D. S., & Patel, S. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.12.027 · Cited by 342
Matrix metalloproteinase-2 and myocardial oxidative stress injury: beyond the matrix
Kandasamy, A. D., Chow, A. K., Ali, M. A. M., & Schulz, R. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvp268 · Cited by 289
Matrix Metalloproteinases as Biomarkers of Atherosclerotic Plaque Instability
Olejarz, W., Łacheta, D., & Kubiak-Tomaszewska, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113946 · Cited by 258
Neutrophil-Derived Matrix Metalloproteinase 9 Triggers Acute Aortic Dissection
Kurihara, T., Shimizu-Hirota, R., Shimoda, M., Adachi, T., Shimizu, H., Weiss, S. J., Itoh, H., Hori, S., Aikawa, N., & Okada, Y. (2012) · Circulation · doi:10.1161/circulationaha.112.097097 · Cited by 256
Endothelial dysfunction and coronary artery disease: assessment, prognosis, and treatment
Matsuzawa, Y., & Lerman, A. (2014) · Coronary Artery Disease · doi:10.1097/mca.0000000000000178 · Cited by 249
Meng, S., Wang, L., Huang, Z., Zhou, Q., Sun, Y., Cao, J., Li, Y., & Wang, C. (2012) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2012.05670.x · Cited by 99
Protease-activatable adeno-associated virus vector for gene delivery to damaged heart tissue
Guenther, C. M., Brun, M. J., Bennett, A. D., Ho, M. L., Chen, W., Zhu, B., Lam, M., Yamagami, M., Kwon, S., Bhattacharya, N., et al. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.01.015 · Cited by 46
“Matrix metalloproteinases (MMPs) are a class of proteases normally involved in the remodeling of extracellular matrix, but they have been found to be upregulated in sites of cardiovascular disease, including myocardial infarction (MI),(7) congestive heart failure,(8,9) and atherosclerosis.(10) In particular, MMP-2 and…”
BackgroundIncretin drugs as modulators of atherosclerosis
Gallego-Colon, E., Wojakowski, W., & Francuz, T. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.09.011 · Cited by 35
CleavPredict: A platform for reasoning about matrix metalloproteinases proteolytic events.
Kumar, S., Ratnikov, B. I., Kazanov, M. D., Smith, J. W., & Cieplak, P. (2015) · PLOS ONE · doi:10.1371/journal.pone.0127877 · Cited by 29
Hall, S., & Agrawal, D. K. (2018) · Drug Delivery and Translational Research · doi:10.1007/s13346-017-0409-0 · Cited by 20
Metadata
- Authors
- Newby, A. C.
- Venue
- Trends in Cardiovascular Medicine
- Publisher
- Elsevier BV
- Published
- 2007-11
- Volume
- 17
- Issue
- 8
- Pages
- 253-258
- ISSN
- 1050-1738 (ISSN-L)
- OpenAlex
- W2015835353
- Cited by
- 253
- References
- 49
- FWCI
- 3.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.